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Re aim of Ihis work was to assess wherher cancel patients presenting high anxiety leveis
or poor adaptation Lo cancer experience hi~her leveis of postchemotherapy nausea,
regardless of the ernetogenicity of the chemotherapy schedule. Sixty-threepatients were
nterviewed before receiving their chemoíherapy schedule and sorne psychological variables
were assessed. Nausea intensity was also assessed after treatment. The results showed
that patients with relatively higher leveis of nausea reported higher leveis of anxiery prior
to chemotherapy and lower leveis of adaptation tu cancer. Thus, evidence for a modulating
eflect of psychologicaL factors in postchernotherapy emesis is suggested.
Kcy words: chetnolherapy nauseo, anxiely, adaptotion fo ilh~ ess
rí objetivo del presente trabajo fue evaluar si los pacientes de cáncer que muestran altos
niveles de ansiedad o una escasa adaptación a la enfermedad experimentan también
una elevada náusea postquimioterapia independientemente del potencial emetizante del
tratamiento. Se entrevistó a 63 pacientes antes de que recibieran uno de los ciclos de
quimioterapia y se evaluaron diferentes variables psicológicas. Asimismo, se registró la
intensidad de náusea postratamiento. Los resultados indican que los pacientes con
mayores niveles de náusea muesiran unes nivetes de ansiedad previos a la quimioterapia
más elevados y unos niveles de adaptación al cáncer más bajos. Se sugiere la posibilidad
de que los tactores psicológicos tengan un etecto modulador de la intensidad de la
náusea postquimioterapia.
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Nausea and vomiting are amongsí [he ínost distressful
side effects of chenaotherapy in canecí patients (Burish &
Carey, 1986; Coates, 1986; GralIa, 1987; Love, Leventhal,
Easter¡ing, & Nereaz, 1989). I-loweve~ nausea and vorniting
afrer ehemotherapy are not (he only emetie side effects
assocjated wjth that trealmení. In fact, 25% of patienis
experienee a phenomenon called “anticipatory nausea and
vomiting,” which is observed when sorne patients exhibit
nausea and vomiting before chemotherapy is adminisrered
(Blasco, 1994; Redd, Burish, & Andrykowski, 1985).
Clinical psychologists have devoted thcir main eflbrts lo
finding out which factors are involved in anlicipatory
symptoms (Andrykowski, Redd, & HatíleId, 1985; Carey &
Burish, 1988; Challis & Starn, 1992; Hursti eL al., 1994:
Kvale ct al., 1991; Morrow, Lindke, & Black, 1991; Watson
& Marvell, 1992), as well as Lo reducing them through
various therapies (Burish & Tope, 1992; Carey & Burish,
1988; Vasterling, Jenkins, Tope, & Burish, 1993). Despite
the extensive research carried out in ihis Iield, researcheis
have not yet gained complete knowledge about how, why,
and in which patients, anúeipatory nausea and vorniting
appear.
In order to extend the seope of Ibis knowledge, facíors
related with anticipatory nausea and vorniting, such as
personalhy traits (Hursri et al., 1992) or individual differcnces
in susceptibility (o autonomie nervous system conditionability
(Frcdrikson et al., 1993; Kvale, Psychol, & Hugdahl, 1994)
have been considered. However, as has been suggested by
Blasco (1994), because andcipatory symptoms do not usually
appear without previous experience of postche¡noíherapy
nausea and/or vomiting, these side effects seem to be one
of tbe main factors in explaining Ibe developrnent of tbe
anhicipatory symptoms. Furthermore, psychological factois
could modulate [he intensity of posrchernotherapy nausca
and vomiting, as sorne stttdies have pointed out
(Andrykowski & Gregg, 1992; Jacobsen et al., 1988; Jenkins
& Burish, 1995).
In this context, the aim of [he present study was to
assess wheíher two psychological factors were related to
postchemorherapy nausea in cancer patients receiving
chemotherapy. The incidence of vomiting was not studied
because patien[s in Ihis study received a new antiemetie
drug (Kytril), which drastically reduced this side effect.
The psychological factors considered in our study were:
a) anxiety prior [o and during the infusion of
chemotherapy. which has been Iinked to postchemotherapy
side effects in sorne studies (Andrykowski & Gregg, 1992;
Jacobsen et al., 1988), and, b) adaptation to canecí: a
concept by which wc attempt to resume the global
psychological síate of the patient. Thus, we hypothesized
[bat cancer patients with bigh leveis of anxie[y aud ponr
leveis of adaptation to illness prior to receiving an infusion
of chemotherapy would experience higher intensities of




Participanís were patients at a large comprehensive cancer
cenier (Hospital de la Santa Creu i Sant Pan, Barcelona,
Spain) and were in[erviewed between October 1993 and May
1994. Parí of a larga study, ihe resulis reported bac are
from 63 patienís, 20 men (31.7%) and 43 women (68.3%),
who: a) consented to be interviewed prior lo receiving their
chemotherapy infusion (see Procedure); b) were receiving
Ihe same antiemetie agent (Kytril); and, e) returned a
notebook, whieh íbey were requested Lo III ‘u at borne lo
assess postchernoíherapy distress (see Procedure).
Thirty-two patients (5(1.8%) had breasí cancer, lO patienís
(15.9%) were treated for sarcoma, 6 patients (9.5%) had a
diagnosis of Long cancer, 7 patients (11.1%) had head and
neck canceis, aud the other 8 patients (12.6%) had various
kinds of cancer (lymphornas, testicular cancer, gynecological
eaneers). Twenty-eight patien[s were reeeiving either [he firsí
or second infusions of chcmotheiapy when interviewcd, 19
patients were reeeiving infusions three or four, whereas Ihe
other 16 patients had received five or more treatment inffisions.
The mean ace of Ihe patients was 48.43 years (SD =
13.28 years), with a minirnurn age of 17 years and a
maxirnum age of 70 years.
Measuremenis
AII mcasurements wcre obtained by lO-cm visual
analogue seales (VAS). VAS have been widely used lo assess
symploms such as anxiety, nausea, or vomiting
(Anduykowski & Gregg, 1992; Bovbjerg eL al., 1992; Challis
& S[am, 1992; Jacobsen el al., 1993; Lindley et al., 1992)
as wcll as other psychological aspecís (Cimprich, 1992:
Mock, 1993), and have been considered an adequate bol
to be used with cancer patients (Coscarelli. 1-leinrich,
Aadland, & Ganz, 1990; Morrow et al., 1992). la our study,
anxiety, nausea intensity, and other somatie symptoms, such
a.s pain, sleep disturbances, or siekness were measured using
VAS before and aher the infusion of chemotherapy. ‘[‘hese
somate sympíoms were assessed in order to prevení patients
from focusing their altention only on nausea and anxiety
and, íherefore, wilI not be included in the results. Nausea
was asscsscd (y a VAS with the sentences. “Since 1 received
the treatrnent tip (o Ihe prcsent, 1 have no[ cxQerienced any
nausea al alí’ on Ihe left side, and “Sinee 1 received the
treatment op lo the presení, 1 have experienced intense
nausea” on Ihe right side. Anxiety was assessed by a VAS
with the sentences, “1 have no anxiety al ah” and “1 feel
very anxiuus now.” Patien[s’ answers were rated as O-lOO
values (with O al the lefí aud lOO aL Ihe right side of LIje
VAS). Thus, Wc highér the raje, the greater the intensity of
the symplorns assessed. More comprehensive information
about Ihese seales can be found in Blasco (1992).
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When [his sludy began, Lhere was only one instrumen[
available it <he Spanish language te assess adaptation te
illness: <he Adaplalion lo Cancer Index (Blasco & Bayés,
1992). Ihis index is derived from a measure of Ihe Quality
of Life, developed by Font (1988). which has been applied
in sorne other studies (Juan, Blasco, FonL, Pallarés, & Sanz,
1999; Pallarés a al., 1996). This insuumeut is a paekage of
27 VAS, whieh assesses Lhe disruption caused by illness in
vaneus aucas of (he patienís life. Disruption is rated en seales
ranging frorn O <o lOO: the higher the rate, Ihe grealer <he
disruption. Frorn Ihis assessment. Lhe AdaptaLion Lo Cancer
índex assumes “adapta<ion’ <o be a relaflonship between the
deinands of Lhe illness and [he paLien<’s disturbed
psycho!egical responses <o them. Thus, it assesscs Ihe
disrup[ion caused by cancer in feur areas: somaLic symptoms
(SYMPT), loss of daily living bablís (HABIT), famfly
relationships (FAMREL), and psychological disLurbanee
(PSYCHO). Adaptation is assessed as <he ratio beíween Ihe
sum of SYMPT, HABIT, and FAMREL seales, and [he
PSYCHO seale multiplied by a constan< of 3:
ADAPTATION = SYMPT + HABIT + FAMREL
3 >4 PSYCHO
Using <bis index, a value el 1 or mere means that Pie
patient is adapLed, because his er her psychological
disturbance is noL higher <han disruplions in <he oLher areas.
On Ihe olber hand, values be<ween O and 1 mean [bat Ihe
patient is noL adapLed, hecause psyehological (listurbance is
higher <han disturbanees in <he other areas. The authors
suggest Lhat <he index should be used no[ as a continuous
variable, buí as a diehotomous measure to classify paLienls
as either “adapted’ or “noL adapted.’
Procedure
PaLients were asked <o participate in <he sLudy just before
reeeiving Iheir ehemo[herapy infusion, and were requested
lo answer sorne questions about Lheir general sLate before
and afler Lhe infusion. Al! paLients received chemotherapy
In an ouLpatien[ sehedule and Were always inLerviewed by
<he saíne txvo female researeheis. Once patienís bad agreed
Lo parLieipate, <he VAS procedure and Lhe general
eharae[eris[ics of Lhe s[udy ~vereexplained. Pa[ienls answered
Ihe queslions jusí hefore reeeiving the infusion and were
provided with a notebook te Lake horne. This notebook alse
centained sorne VAS whieh assessed: a) the anxiety
experienced during <he infusion; b) nausea and vomiting
afler chemotherapy, and e) other somalie side effects such
as sickness. sleep disorders, and pain. In the noLebook, <he
patien[ assessed íwo 24-hour periods, Lhal is, Ihe day
ehemotherapy was administered and <he day afLen PaLients
received instrucLions Lo 1111 in Lhe no[ebooks before going
Lo bed on botb days. Wben pa<ients came baek [o the bospiLal
for Lhe next cheniotherapy infusion, [bey returned <he
notebook <o <he researehers. Because íwo values of nausea
intensity were recerded in the notebook, Ihe highes< value
was always considered <he measure of postchemotherapy
nausea. Similarly, <he highest value of anxiety (“anxiety
before receiving Ihe infusion’ and “anxiety during <he
infusion’) was considered as LhC measure of anxiety <o be
analyzed ¡u the results.
Two groups of ehemo[herapy sehedules were considered
aecording Lo Ihe ratings by physicians of the Oneology
Service VitI (Stam & Challis, 1989): schedules with high
emetogenicity (con[aining císplaLin), and sehedules wi<h
moderate ernetogenieity (wiLhout cisplaLin).
Síatistical Analyses
Follewing [he me<hodology applied by Andrykowski and
Cregg (1992) and Jacobsen eL al. (1988, 1993, 1995), a
multiple regression analysis, using <he sLepwise tne<hod, was
performed ori <he following variables: anxiety leve!
(considered as a eonlinuous variable), adapLa[ion level
(considered as a diehotomous variable), emetogenicity level
(considered as a dicho<onious variable), sex, age, and number
of infusions previously received. Ihis ana!ysis was performed
wilh [he S<aíistical Package SPSS 7.5 2S for Windows.
Resulís
The analysis indicated <bat [he distribution of one of [he
independeut variables (anKiety) was uo normal. Rus, anxiety
was dichotomized (wi[h high-anxious padenís showing a rate
higher or equal fo 45 and low-anxious paLien[s showing a
rute lower [han 45). Ihe resul<s confirmed [he relationship
beLween nausea inlensi[y and <he variables “adaptalion level’
and “anxie[y level,’ whieh aeeounled for 24% of <he variance
(multiple R = .49, F(2, 57) = 9.25, p = .0003). The remaining
variables were not included in [he s<epwise equaLion. Thus,
patien[s with higher levels of nausea tended <o have higher
leveis of anxiety (13 = .333) and poerer leveis of adap[a<ion
«3 = —.290). The high <olerance value ob<ained (.938)
indica[ed that <he Iow eorrelations between variables did noL
cause multicollinearity. Re distribution of the reslúnais was
normal but nol random; and they showed homogenous
variances. It mus[ be coneluded tha< sorne oLher variables
thaI are nol included in <he analysis could aceount for tbe
variance of Ihe nausea inlensity.
Diseussion
Our resul<s suppor< Ihe hypo[hesis [ha[ psychological
facLors are related to nausea in<ensity despite phannacologic
variables. Patienís reporLiflg high level of anxiety and/or a
poor leve! of adap[ation w illness before reeeiving
chemotherapy experienced higher nausea intensity, regardless
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of sez, age, drug sehedule administered, and number of
infusions previously received, althougb <be regression analysis
revealed <bat sorne olber variables, not assessed in ow study,
aecount for the varianee observed in nausea intensi<y.
Re role of anxiety is nor surp¡isirig since anxiety seems
[o be elearly related to emesis in pa[ien<s receiving
cheniotherapy (Andrykowski, 2990; Andrykowski & Gregg,
1992) although lIs causal role rernains unelear (Andrykowski,
1990; Blasco, 1994). Thus, anxiety can be considered boíh
a prognostie factor of inereased postchemotherapy side
effee[s and a target syrnptom lo be treated in erder <o reduce
<he distress experienced by pa<ients receiving chemoLherapy.
In fact, Jacobsen, Bovjerg, and Redd (1993) observed
anticipatory anxiety states iii women receiving chemotberapy.
However, anxie[y rnay be an outcome of poor adaptaLion te
cancer, as is discussed below.
Why is poer adaptation te caneer also related [o inereased
leveis of postehemotherapy nausea? Ip our opinion, adaptation
te caneer refleets whether or foL <he patient suffers from a
distressed psyehological state (depression, subjective health
impairment, feelings of anxiety, and fears aboní illness),
wbich is caused by Ihe experienee of illness, and nol
exclusively by <he ehernotberapy itself. This emotional stale
could inerease <he side effects produced by chemo[herapy
or, aL least, i[ could worsen an impaired subjective s[ate. This
negative modulation is not surprising, sinee a posiLive
modulation was found in <he placebo effeet (Lewis, Lewis,
& Tauersfield, 1984) or, more recen[ly, in cancer survival
(Fawzy eL al., 1993; Spiegel, Bloom, Kraemer, & Gottheil,
1989). In etber words, it implies <bat psychological factois
could modulate postchemotherapy nausea. However, sorne
features of tbe present study musí be pointed cut.
Regression analysis indicated that nausea intensity was
not eornpletely explained by anxiety and adap[a[ion level.
Which otber variables cot¡ld explain nausea? Wc do ncC
know. Perhaps [he beterogenous sample of diagnoses could
be responsible of this limitation of cur s[udy. This possibility
cannot be exeluded, but Andrykowski and Gregg (1992) did
ncC use a hornogenous sample of diagnoses and found thai
psychological variables accounted for <he 13.5% of [he
vananee. 1-Iowever, neitber Andrykowski ¿rnd Gregg (1992)
por Jacobsen e[ al. (1988, 1993, 1995) specified <he accuracy
of Cheir analyses of residuals en Cheir regression models, so
perhaps <beir studies had <he same limitations of ours.
Our results do not agree witb <bose previously reported
by Andrykowski and Gregg (1992), whe observed in Iheir
regression model that <he emetie potential of <he
chemotherapy sehedule accounted for some of [he variance
of <he nausea intensity. This diserepaney may be due lo two
reasons: a) our consideration of <he ernetie potential as a
dichotornous variable, and, b) our measures of anxiety and
nausea ;n<ensily, which were no[ <reated as <he mean of
several measures obtained in a longitudinal study.
On <be other hand, we evaluated only certain kinds of
patients and cbemo[berapy sehedules. Researcb with larger
samples, using accurate longitudinal studies assessing <he
whole experience of ehemotherapy, is needed lo confirm
whecher anxiecy and adaptation te illness are always related
<o <he in<ensity of postchemorberapy nausea, regardless of
Che degree of emetogenicity of Che chemotherapy schedule
administered, aud wbetber this rela<ionship could be a causal
one. II this were Che case, clinical sírategies lar Che treatment
of chernotherapy-induced nausea and vorni<ing could be
applied more aecurately. Tbese sirategies eould be preventive
and addressed lo managing speciftc factors [bat appear jus[
before treaímen<, such as anxiety or lack of information
(Burish, Carey, Krozely, & Greco, 1987; Burish, Snyder, &
Jenkins, 1991; Jacobsen ci al., 1995). However, <bis
prevention eculd also be achieved by treatmen[s addressing
dis<ressful psychelogical feelings (i.e., fears abeut the illness,
subjee<ive bealth impairmen<) that are presen< along <he life-
span of caneer patienis reeeiving long trea[men<s such as
ehemotherapy. In <bis case, perhaps a global <berapeutie
approacb, aceording <o [he features developed by Fawzy,
Fawzy, Arání, and Pasnan (1995), and Fawzy and Fawzy
(1998) based en a s<ructured inlervention consis<ing ori health
edueation, stress rnanagement/behavioral training, coping
including prohlem-solving <ecbniques, and psychosocial
group support, could help paLien<s <o avoid postehemolherapy
nausea, as welI as o[ber negative features associated with
[be experience of caneer (Hitch. Fielding, & Llewelyn, 1994;
Meyer & Mark, 1995),
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